Physician Assistant · Manteca, CA
NPI
1457133738
Since 2023
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
296 Cottage Ave
Manteca, CA, 95336
Phone (209) 624-7006
Groups this clinician bills Medicare through
Medicare paid, 2024
$229K
4,455 services
Medicare patients, 2024
476
Average age 76
Drug cost, 2024
$627K
963 prescriptions
Company payments, 2025
$4,696
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Trevor M Dolling was code 17003 (destruction skin lesion), 1,943 times for 246 patients. In total Trevor M Dolling billed 4,455 services in 45 codes, and Medicare paid $229K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-01-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,943 | 246 | $4.70 | $9,123 |
| 99213 Office E&M - Established | Office | 584 | 348 | $58.77 | $34K |
| 17000 Destruction Skin Lesion | Office | 418 | 281 | $34.10 | $14K |
| 11102 Skin Biopsy | Office | 275 | 225 | $59.65 | $16K |
| 17110 Destruction Skin Lesion | Office | 168 | 132 | $76.77 | $13K |
| 0394T Conventional Radiation Treatment | Office | 156 | 17 | $111.36 | $17K |
| 77600 Radiation Oncology | Office | 128 | 16 | $392.71 | $50K |
| 99203 Office E&M - New | Office | 121 | 121 | $62.47 | $7,559 |
| 77280 Radiation Treatment Planning | Office | 118 | 15 | $194.22 | $23K |
| 17004 Destruction Skin Lesion | Office | 112 | 84 | $109.21 | $12K |
| 11103 Skin Biopsy | Office | 86 | 65 | $34.09 | $2,932 |
| 99214 Office E&M - Established | Office | 74 | 43 | $85.81 | $6,350 |
| 99212 Office E&M - Established | Office | 74 | 62 | $37.16 | $2,750 |
| 11104 Skin Biopsy | Office | 18 | 17 | $82.12 | $1,478 |
| 12032 Wound Repair - All Levels | Office | 18 | 16 | $213.76 | $3,848 |
Medicare prescription drug claims, 2024
In 2024, the drug Trevor M Dolling prescribed most often to Medicare patients was Ketoconazole, with 125 prescriptions and refills. In total Trevor M Dolling wrote 963 Medicare prescriptions that cost $627K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 125 | 140 | 73 | $2,405 |
| Mupirocin Generic | 121 | 122 | 89 | $649 |
| Clobetasol Propionate Generic | 107 | 113 | 64 | $4,289 |
| Triamcinolone Acetonide Generic | 86 | 89 | 67 | $917 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 73 | 73 | 49 | $1,317 |
| Tacrolimus Generic | 50 | 50 | 32 | $6,997 |
| Fluorouracil Generic | 41 | 42 | 37 | $2,784 |
| Dupixent Pen Dupilumab | 28 | 28 | Under 11 | $98K |
| Doxycycline Hyclate Generic | 24 | 29 | 18 | $265 |
| Sotyktu Deucravacitinib | 23 | 23 | Under 11 | $156K |
| Calcipotriene Generic | 23 | 24 | 17 | $3,870 |
| Betamethasone Dipropionate Generic | 21 | 21 | Under 11 | $1,130 |
| Tretinoin Generic | 16 | 20 | 15 | $1,247 |
| Nystatin-Triamcinolone Nystatin/Triamcinolone Acet | 15 | 15 | Under 11 | $259 |
| Mometasone Furoate Generic | 15 | 15 | Under 11 | $152 |
Brand drugs: 138 claims; generic drugs: 825 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Trevor M Dolling $4,696 ($4,696 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbvie Inc. with $727.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 25 | $727 |
| Incyte Corporation INCY | 30 | $704 |
| Genzyme Corporation SNY | 11 | $614 |
| Janssen Biotech, Inc. JNJ | 12 | $613 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 8 | $379 |
| Regeneron Healthcare Solutions, Inc. REGN | 15 | $361 |
| Arcutis Biotherapeutics, Inc. ARQT | 7 | $287 |
| E.R. Squibb & Sons, L.L.C. BMY | 9 | $248 |
| Galderma Laboratories, L.P. GALD.SW | 11 | $233 |
| UCB, Inc. UCB.BR | 14 | $184 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.